Clinical Trials on Primary Central Chondrosarcoma

Total 308902 results

OHSU Knight Cancer Institute
Novartis Pharmaceuticals; Oregon Health and Science University

Completed

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Adult Alveolar Soft Part Sarcoma | Adult Angiosarcoma | Adult Desmoplastic Small Round Cell Tumor | Adult Epithelioid Hemangioendothelioma | Adult Epithelioid Sarcoma | Adult Extraskeletal Myxoid Chondrosarcoma | Adult Extraskeletal... and other conditions

United States
Johns Hopkins University
National Institute of Mental Health (NIMH); University of Michigan

Recruiting

Clinic-based HIV Identification and Prevention Project Using Electronic Resources (CHIPPER)

PrEP | HIV Prevention | Primary Care

United States
Alnylam Pharmaceuticals

Completed

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria Type 1 (PH1)

France, United Kingdom, Netherlands, Israel, Germany
Eli Lilly and Company

Completed

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

Metastatic Cancer | Advanced Cancer

United States, Canada
Memorial Sloan Kettering Cancer Center

Completed

Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal | Fallopian Tube

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Galaxy Pharma (Pvt) Limited
Ova IVF & Reproductive Health Clinics, Karachi

Recruiting

Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF (MSP-INVO IVF)

Secondary Infertility | Primary Infertility | Low Responders | Mild to Moderate Male Factor Infertility

Pakistan
Nantes University Hospital

Completed

Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer (IMEPOCA)

Metastatic Cancer
Centre Hospitalier Universitaire de Besancon

Unknown

Primary Headache and Psychological Factors, Mental Functioning and Attachment Modalities. (CEPRIVA)

Primary Headache Disorder

France
National Taiwan University Hospital

Completed

Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis

Primary Glomerulonephritis

Taiwan
Stanford University

Completed

Assessing the Diagnostic Accuracy of an On-line Questionnaire for Diagnosis of Primary Headache Disorders

Headache Disorders

United States
Istituto Clinico Humanitas

Completed

Retrospective Comparison of Pregnancy Outcome of Infertile Patients After Fresh and Warmed Single Blastocyst Transfer From 2014 to 2018.

Primary Maternal and Neonatal Outcomes; Assisted Reproductive Technology
Hospices Civils de Lyon

Completed

IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA (PH1)

Idiopathic Hypercalciuria | Primary Hyperoxaluria Type 1

France
Ankara City Hospital Bilkent

Active, not recruiting

Effectiveness of Eye Mask and Noise Reduction Headset in Primary Headache

Primary Headache Disorder

Turkey
Aksaray University Training and Research Hospital

Completed

Oxygen Therapy for Headache

Primary Headache Disorder

Turkey
Scott and White Hospital & Clinic
Endo Pharmaceuticals

Completed

Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals (MAM)

Bleeding | Migraines | Spotting

United States
University Hospital, Strasbourg, France

Recruiting

Impact of the Development of Pediatric Palliative Care (PTB)

Primary Brain Tumor

France
University of Arkansas

Withdrawn

The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients

Neoplasms by Site | Metastatic Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Adult Angiosarcoma | Adult Epithelioid Sarcoma | Adult Extraskeletal Osteosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma and other conditions

United States, Canada, Australia, New Zealand, Puerto Rico
VA New York Harbor Healthcare System
Mayo Clinic; New York University

Unknown

Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients

Oxalate, Primary Hyperoxaluria, Microbiome

United States
Ankara City Hospital Bilkent

Completed

Ovarian Reserve and Matrix Metalloproteinases

Oxidative Stress | Ovarian Failure, Premature | Ovarian Insufficiency, Primary

Turkey
Dicerna Pharmaceuticals, Inc.

Completed

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients (PHYOX4)

Primary Hyperoxaluria Type 3

United States, Germany, Netherlands, United Kingdom
University of Cologne

Completed

Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate (PHOX-B6-Pilot)

Primary Hyperoxaluria Type I

Germany
Massachusetts General Hospital

Completed

rTMS as a Treatment for PPA

Logopenic Variant Primary Progressive Aphasia | Non-Fluent Primary Progressive Aphasia

United States
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Enrolling by invitation

Long Term Extension Study in Patients With Primary Hyperoxaluria (PHYOX3)

Kidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)

United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Active, not recruiting

Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

Primary Central Nervous System Lymphoma (PCNSL)

United States
Technische Universität Dresden
Gert und Susanna Mayer Stiftung

Recruiting

Neurocognitive Function After Proton Therapy in Children and Adolescents (ELBE-ProKids)

Primary Brain Tumor

Germany
University Hospital, Strasbourg, France

Recruiting

Phenotyping of Primary Hyperoxaluria (PHENO-HOPLA)

Primary Hyperoxaluria

France
University of Michigan
Emory University; University of California, San Francisco; Research Foundation...

Completed

A Couples-based Intervention for Transgender Women and Their Partners (T2)

HIV Infections | HIV Primary Infection

United States
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Recruiting

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function (PHYOX8)

Primary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary Hyperoxaluria

United States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
Biocodex
Exystat

Not yet recruiting

Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 (CRYSTAL)

Primary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1
Antonio Francesco Urbino
Scuola Superiore di Osteopatia Italiana

Unknown

Effectiveness of Osteopathic Manipulative Therapy in Paediatric Patients, With High Frequency Headache.

Headache Disorders | Primary Headache Disorder

Italy
University Hospital, Rouen

Completed

Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients (DICAM)

Kidney Transplantation | Primary Prevention | Kidney Failure
Universidad de León

Completed

Effects of Perineal Massage (PERMAS) (PERMAS)

Obstetric Labor Complications | Primary Prevention | Musculoskeletal Manipulations | Physical Therapy Modalities

Spain
Lagos State University

Unknown

Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.

Primary Postpartum Haemorrhage
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada, United Kingdom, Australia
M.D. Anderson Cancer Center
Sanofi-Synthelabo

Completed

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Unknown Primary Neoplasms

United States
Duke University

Completed

Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer

Primary Brain Tumor | Brain Metastases, Adult

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada, United Kingdom, Australia
Mayo Clinic
National Institutes of Health (NIH); Oxalosis and Hyperoxaluria Foundation...

Withdrawn

International Registry for Primary Hyperoxaluria

Kidney Stones | Nephrocalcinosis | Primary Hyperoxaluria

United States
CSL Limited

Completed

Subcutaneous Ig NextGen 16% in PID Patients

Primary Immunodeficiency (PID)

Australia, New Zealand
Massachusetts General Hospital
National Institute on Deafness and Other Communication Disorders (NIDCD)

Recruiting

TMS for the Treatment of Primary Progressive Aphasia

Logopenic Variant Primary Progressive Aphasia | Non-fluent Variant Primary Progressive Aphasia | Semantic Variant Primary Progressive Aphasia

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI); Eli Lilly and Company

Completed

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Ono Pharmaceutical Co. Ltd

Recruiting

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Primary CNS Lymphoma | Refractory Primary Central Nervous System Lymphoma

United States
Rigshospitalet, Denmark

Completed

Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Unknown Primary Tumor

Denmark
Swansea University

Completed

Psychological Context Effects

Control Condition | Positive Communication (Primary) | Negative Communication

United Kingdom

Clinical Trials on Primary Central Chondrosarcoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations